Michael Kilby

Michael Kilby Partner

Michael Kilby

Education

  • University of Toronto (J.D. 2005)
  • University of Toronto (M.A. Economics 2005)
  • McMaster University (B.Arts.Sc. 2002)

Bar Admission

  • Ontario, 2006
Representative Work
  • BayMark Health Services, Inc., a portfolio company of Webster Capital, as co-counsel, in its acquisition of Canadian Addiction Treatment Centres LP, the largest provider of opioid addiction treatment in Canada.
  • MedReleaf Corp. in its proposed C$3.2B acquisition by Aurora Cannabis Inc.
  • Patheon N.V., as Canadian counsel, in its US$7.2B acquisition by Thermo Fisher Scientific Inc.
See allRepresentative Work
Accolades
  • Chambers Canada 2018 as a leading lawyer in Competition/Antitrust, with clients noting that he is a “very skilled practitioner” who is “very rigorous in his analysis.”
  • Chambers Global 2018 as a leading lawyer in Competition/Antitrust.
  • Global Competition Review’s GCR 100 2018 as a recognized lawyer in Stikeman Elliott’s “elite” Competition Group.
See allAccolades
Speaking Engagements
  • “New National Security Review Guidelines”, Canadian Bar Association, Brown Bag Seminar, January 2017.
  • “Due Process in Foreign Investment Review”, Canadian Bar Association, Competition Law Fall Conference, Ottawa, October 2016.
  • “Merger Diligence – Cross-Border Compliance Considerations”, American Bar Association, Brown Bag Seminar, January 2016.
See allSpeaking Engagements